Browse: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 3 |
Genentech, Inc. patentsThe following is a sampling of recent Genentech, Inc. patent applications (USPTO Patent Application #, Patent Title) sorted by month.
April 2008 - Genentech, Inc. patents
20080095771 - Treatment method 20080095773 - Polypeptides homologous to vegf and bmp1 20080096215 - Compositions and methods for the diagnosis and treatment of tumor 20080085886 - Aza-benzofuranyl compounds and methods of use 20080081821 - Aza-benzothiophenyl compounds and methods of use March 2008 - Genentech, Inc. patents
20080075719 - Method for augmenting b cell depletion 20080063641 - Monovalent antibody fragments useful as therapeutics 20080057066 - Methods and compositions for targeting relt 20080057503 - Methods and compositions for detecting autoimmune disorders February 2008 - Genentech, Inc. patents
20080050310 - Antibodies and immunoconjugates and uses therefor 20080050364 - Treatment of lfa-1 associated disorders with increasing doses of lfa-1 antagonist 20080050373 - Treatment with anti-erbb2 antibodies 20080050377 - Compositions and methods relating to stop-1 20080050758 - Secreted and transmembrane polypeptides and nucleic acids encoding the same 20080044415 - Hepatocyte growth factor receptor antagonists and uses thereof 20080044421 - Methods of using death receptor ligands and cd20 antibodies 20080038264 - Compositions and methods for the treatment of immune related diseases 20080038717 - Enrichment method for variant proteins with altered binding properties 20080031875 - Treatment method 20080031880 - Use of erbb receptor ligands in treating diabetes 20080032343 - Recombinant production of heparin binding proteins January 2008 - Genentech, Inc. patents
20080025971 - Humanized anti-beta7 antagonists and uses therefor 20080026426 - Anti-infective therapy 20080014196 - Compositions and methods for modulating vascular development 20080008705 - Cancer prognostic diagnostic and treatment methods 20080003218 - Anti-ige antibodies December 2007 - Genentech, Inc. patents
20070298036 - Pro71238 polypeptides 20070299052 - Inhibitors of iap 20070292419 - Treatment with anti-erbb2 antibodies 20070292438 - Novel gene disruptions, compositions and methods relating thereto 20070292936 - Binding polypeptides with optimized scaffolds 20070280931 - Antibody variants November 2007 - Genentech, Inc. patents
20070274995 - Cardiotrophin-1 compositions and methods for the treatment of tumor 20070269371 - Antibodies with altered effector functions 20070269429 - Treatment with anti-erbb2 antibodies 20070269446 - Compositions and methods for the treatment of tumor of hematopoietic origin 20070264193 - Diagnostics and treatments for tumors 20070264259 - Methods for treating kidney disorders 20070264267 - Compositions and methods for treatment of cancer 20070264686 - Secreted and transmembrane polypeptides and nucleic acids encoding the same 20070258984 - Treatment with anti-vegf antibodies 20070259398 - Microwave assisted deglycosylation of proteins for molecular weight determination by mass spectrometry 20070253948 - Anti-fc-gamma riib receptor antibody and uses therefor 20070253959 - Vascular endothelial cell growth factor antagonists 20070254302 - Compositions and methods for the diagnosis and treatment of tumor October 2007 - Genentech, Inc. patents
20070248588 - Novel compositions and methods for the treatment of immune-related diseases 20070248604 - Anti-fgf19 antibodies and methods using same 20070248610 - Anti-vegf antibodies 20070250941 - Vegf receptor conditional knockout animals and methods of use 20070243193 - Compositions and methods for the diagnosis and treatment of tumor 20070237774 - Method for using boc/cdo to modulate hedgehog signaling 20070238642 - Production of vascular endothelial cell growth factor and dna encoding same 20070238859 - Pro9925 polypeptides 20070231323 - Compositions and methods for the diagnosis and treatment of tumors of glial origin 20070231324 - Methods of using death receptor ligands and cd20 antibodies 20070231328 - Method of treatment using humanized anti-cd11a antibodies September 2007 - Genentech, Inc. patents
20070224185 - Secreted and transmembrane polypeptides and nucleic acids encoding the same 20070224201 - Compositions and methods for the diagnosis and treatment of tumor 20070218069 - Methods and compositions for targeting polyubiquitin 20070212356 - Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling 20070212362 - Use of il-17 antibody for the treatment of cartilage damaged by osteoarthritis 20070212735 - Compositions and methods for the diagnosis and treatment of tumor 20070207142 - Compositions and methods for the treatment of tumor of hematopoietic origin 20070207147 - Secreted and transmembrane polypeptides and nucleic acids encoding the same August 2007 - Genentech, Inc. patents
20070202045 - Serum albumin binding peptides for tumor targeting 20070202516 - Gene detection assay for improving the likelihood of an effective response to an egfr antagonist cancer therapy 20070196374 - Anti-vegf antibodies 20070190058 - Method for treating intraocular neovascular diseases 20070184055 - Treatment with anti-erbb2 antibodies 20070184444 - Compositions and methods for the treatment of immune related diseases 20070185017 - Compositions and methods for the treatment of immune related diseases 20070178486 - Compositions and methods for the diagnosis and treatment of tumor 20070178539 - Novel cytokine receptors and nucleic acids encoding the same 20070179088 - Foggy 20070179091 - Hedgehog kinases and their use in modulating hedgehog signaling July 2007 - Genentech, Inc. patents
20070174922 - Nucleic acid encoding novel type-1 cytokine receptor glm-r 20070166753 - Gene detection assay for improving the likelihood of an effective response to a her2 antibody cancer therapy 20070160576 - Il-17a/f heterologous polypeptides and therapeutic uses thereof 20070160594 - Method of diagnosing and treating cartilaginous disorders 20070160598 - Binding polypeptides with diversified and consensus vh/vl hypervariable sequences 20070160608 - Treatment with anti-vegf antibodies 20070160612 - Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders 20070160618 - Cardiotrophin-1 compositions and methods for the treatment of tumor 20070161061 - Novel composition and methods for the treatment of immune related diseases 20070161558 - Production of vascular endothelial cell growth factor and dna encoding same 20070161564 - Methods for making apo-2 ligand using divalent metal ions 20070154391 - Antibodies to vascular endothelial cell growth factor 20070154483 - Treatment with anti-vegf antibodies June 2007 - Genentech, Inc. patents
20070148177 - Treatment with anti-vegf antibodies 20070148178 - Treatment with anti-vegf antibodies 20070141023 - Assays and methods using biomarkers 20070141066 - Method for diagnosing, prognosing and treating glioma 20070141068 - Methods for the treatment of carcinoma 20070141630 - Identification of non-covalent complexes by mass spectrometry 20070143871 - Non-human transgenic animal models for hepatocellular carcinoma 20070134243 - Antibody drug conjugates and methods 20070134251 - Assays and methods using biomarkers 20070136829 - Novel type-1 cytokine receptor glm-r 20070129301 - Methods and compositions for modulating hgf/met May 2007 - Genentech, Inc. patents
20070122394 - Compositions and methods for liver growth and liver protection 20070122407 - Isolated nucleic acids, vectors and host cells encoding erbb3 antibodies 20070116700 - Reduced-viscosity concentrated protein formulations 20070117124 - Achaete-scute like-2 polypeptides and encoding nucleic acids and methods for the diagnosis and treatment of tumor 20070110755 - Vascular endothelial cell growth factor antagonists 20070098634 - Compositions and methods for the diagnosis and treatment of tumor 20070098681 - Apo-2 ligand/trail variants and uses thereof 20070098707 - Methods and compositions for inhibiting c-met dimerization and activation April 2007 - Genentech, Inc. patents
20070092520 - Humanized anti-cmet antagonists 20070092890 - Methods and compositions for detecting autoimmune disorders 20070092940 - Cysteine engineered antibodies and conjugates 20070086995 - Methods of treating ige-mediated disorders comprising the administration of high concentration anti-ige antibody formulations 20070087006 - Compositions and methods for the diagnosis and treatment of tumor 20070081995 - Methods and compositions for targeting ifnar2 20070077243 - Method for making humanized antibodies 20070077625 - Purification of polypeptides 20070077626 - Polypeptides sharing sequence identity with a fibroblast growth factor polypeptide and nucleic acids encoding the same March 2007 - Genentech, Inc. patents
20070048218 - Compositions and methods for the diagnosis and treatment of tumor 20070048301 - Compositions and methods for the treatment of immune related diseases 20070048326 - Compositions and methods for the diagnosis and treatment of tumor 20070048822 - Erbb4 receptor-specific neuregulin related ligands and uses therefor 20070048825 - Compositions and methods for the diagnosis and treatment of tumor 20070049516 - Use of insulin for the treatment of cartilaginous disorders 20070049601 - Benzofuran inhibitors of factor viia 20070049730 - Patched-2 antibodies February 2007 - Genentech, Inc. patents
20070041969 - Apo-2dcr 20070041970 - Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders 20070041983 - Method for treating tumors using anti-osteopontin antibodies 20070042415 - Anti-fused antibodies 20070042395 - Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity 20070042466 - Il-1 related polypeptides 20070042945 - Nouvelles compositions et methods de traitement du psoriasis 20070036753 - Treatment with anti-vegf antibodies 20070036754 - Treatment with anti-vegf antibodies 20070036755 - Treatment with anti-vegf antibodies 20070036782 - Apo-2 ligand 20070036790 - Treatment with anti-vegf antibodies 20070036813 - Vegf-related protein 20070037148 - Compositions and methods for the treatmetn of natural killer cell related diseases 20070037191 - Apo-2dcr 20070037254 - Expression vectors and methods 20070037255 - Antibody variants with faster antigen association rates 20070037741 - Novel compositions and methods for the treatment of immune related disease 20070037813 - Serine protease inhibitors 20070037814 - Acylsulfamide inhibitors of factor viia 20070031331 - Treatment of disorders 20070031413 - Treatment with anti-vegf antibodies 20070031437 - Compositions and methods for modulating vascular development 20070031901 - Compositions and methods for the diagnosis and treatment of tumor 20070031929 - Polypeptides homologous to vegf and bmp1 20070025987 - Method for treating vasculitis 20070025988 - Method for treating lupus 20070025999 - Treatment with anti-vegf antibodies 20070026000 - Apo-2l receptor agonist and cpt-11 synergism 20070026001 - Apo-2 ligand-anti-her-2 antibody synergism 20070026002 - Inhibitors of angiopoietin-like 4 protein, combinations, and their use 20070026044 - Use of vegf for treating bone defects 20070026450 - Methods for the treatment of carcinoma 20070026496 - Process for producing polypeptides 20070027083 - Human growth hormone aqueous formulation January 2007 - Genentech, Inc. patents
20070020256 - Methods for treatment of allergic asthma 20070020258 - Immunoglobulin variants 20070020260 - Glycoprotein compositions 20070020264 - Serum albumin binding peptides for tumor targeting 20070020276 - Methods for the treatment of carcinoma 20070021342 - Wound healing 20070014779 - Plasminogen activator variant formulations 20070014794 - Method for making heteromultimeric polypeptides 20070014797 - Method for treating sjogren's syndrome 20070015228 - Assay for antibodies 20070015247 - Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method 20070009523 - Polypeptide variants with altered effector function 20070010434 - Novel compositions and methods for the treatment of immune related diseases 20070004009 - Methods for making recombinant proteins using apoptosis inhibitors December 2006 - Genentech, Inc. patents
20060292150 - Methods of using wisp antagonists 20060293235 - Hgf beta chain variants 20060286640 - Process for production of polypeptides 20060287234 - Wound healing 20060281146 - Novel compositions and methods for the treatment of immune related diseases 20060281680 - Methods and compositions for modulating vascular integrity 20060275306 - Protein formulation 20060276435 - Fibroblast activation protein inhibitor compounds and methods November 2006 - Genentech, Inc. patents
20060270003 - Il-17a/f heterologous polypeptides and therapeutic uses thereof 20060270594 - Methods and compositions for modulating hyperstabilized c-met 20060263349 - Pretreatment of a biological sample from an autoimmune disease subject 20060263774 - Compositions and methods for the treatment of immune related diseases 20060263808 - C-met mutations in lung cancer 20060257390 - Catheter composition and uses thereof 20060257971 - Antibodies to pro1561 polypeptide 20060258574 - Novel compositions and methods for the treatment of psoriasis 20060251662 - Compositions and methods for the treatment of tumor of hematopoietic origin 20060246004 - Antibody variants and uses thereof 20060246050 - Catheter composition and uses thereof 20060246471 - Compositions and methods for screening pro-apoptotic compounds October 2006 - Genentech, Inc. patents
20060240007 - Method for treating dementia or alzheimer's disease 20060240008 - Therapy of autoimmune disease in a patient with an inadequate response to a tnf-alpha inhibitor 20060233797 - Treatment of inflammatory bowel disease (ibd) 20060234306 - Assay method 20060228364 - Serum albumin binding peptides for tumor targeting 20060228745 - Gene detection assay for improving the likelhood of an effective response to an erbb antagonist cancer therapy September 2006 - Genentech, Inc. patents
20060210556 - Novel composition and methods for the treatment of immune disorders 20060210561 - Dosages for treatment with anti-egfr antibodies 20060210570 - Methods and compositions for modulating prostasin 20060211612 - Angiogenesis using hepatocyte growth factor 20060204493 - Heteromultimeric molecules 20060198843 - Treatment with anti-erbb2 antibodies and chemotherapeutic agents 20060199181 - Compositions and methods for the treatment of immune related diseases August 2006 - Genentech, Inc. patents
20060193851 - Human anti-factor ix/ixa antibodies 20060193854 - Humanized anti-erbb2 antibodies and treatment with anti-erbb2 antibodies 20060193862 - Vascular endothelial cell growth factor antagonists 20060194283 - Secreted and transmembrane polypeptides and nucleic acids encoding the same 20060194290 - Polypeptide variants with altered effector function 20060194291 - Polypeptide variants with altered effector function 20060194954 - Polypeptide variants 20060194957 - Polypeptide variants with altered effector function 20060188495 - Treatment method 20060188498 - Methods of using death receptor agonists and egfr inhibitors 20060188509 - Extending time to disease progression or survival in cancer patients 20060182739 - Protein purification 20060182751 - Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use 20060182755 - Novel composition and methods for the treatment of psoriasis 20060183784 - Human growth hormone antagonists 20060177448 - Inhibiting her2 shedding with matrix metalloprotease antagonists 20060177897 - Pr1550 polypeptides and nucleic acids encoding the same July 2006 - Genentech, Inc. patents
20060165702 - Fixed dosing of her antibodies 20060167066 - Pyrrolidine inhibitors of iap 20060160997 - Compositions and methods for the diagnosis and treatment of tumor 20060147373 - Compositions and methods for the diagnosis and treatment of tumor 20060147374 - Compositions and methods for the diagnosis and treatment of tumor 20060147451 - Modulators of hepatocyte growth factor activator 20060147453 - Methods and compositions for modulating and detecting wisp activity
###
This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Genentech, Inc. in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Genentech, Inc. with additional patents listed. Browse our Agent directory for other possible listings.
###
FreshPatents.com Support
|